Related Experiment Videos

Homocysteine compounds which influence the growth of a malignant neoplasm

Chemotherapy
|January 1, 1977
PubMed

Insights

Researchers explored homocysteine derivatives for cancer treatment. Certain compounds inhibited tumor growth in mice, suggesting a novel therapeutic strategy for human malignancy using biochemical constituents.

Area of Science:

  • Biochemistry
  • Oncology
  • Pharmacology

Background:

  • Homocysteine metabolism plays a crucial role in regulating both normal and abnormal cellular growth.
  • Understanding these metabolic pathways is key to developing novel therapeutic strategies for cancer.

Purpose of the Study:

  • To synthesize and evaluate the effects of three homocysteine derivatives on the growth of transplanted murine adenocarcinoma.
  • To identify potential anticancer agents derived from homocysteine.

Main Methods:

  • Synthesis of three distinct homocysteine derivatives: arachidonoyl homocysteine thiolactone (HCT) amide, oleoyl HCT amide, and pyridoxal HCT enamine.
  • Administration of these compounds to mice bearing transplanted murine adenocarcinoma.
  • Assessment of tumor growth inhibition or enhancement.

Main Results:

  • Arachidonoyl HCT amide and pyridoxal HCT enamine demonstrated significant inhibition of tumor growth.
  • Oleoyl HCT amide was observed to enhance tumor growth.
  • Pyridoxal HCT enamine showed efficacy when administered pre-transplantation but not post-transplantation.
  • The inhibitory compounds were generally well-tolerated in normal mice, with adverse effects noted only at high doses.

Conclusions:

  • Homocysteine derivatives hold promise as a novel approach for the prevention and therapy of human malignancies.
  • Specific derivatives, like arachidonoyl HCT amide and pyridoxal HCT enamine, exhibit anticancer properties.
  • Further research into homocysteine-based therapies could lead to new treatments for cancer by leveraging normal biochemical constituents.

Related Concept Videos